期刊文献+

人胰高血糖素样肽-1突变体基因的克隆及表达 被引量:4

Expression and Cloning of Human Glucagon-like Peptide-1 Mutant Gene
下载PDF
导出
摘要 目的 :克隆人胰高血糖素样肽 - 1突变体 (2 Gly -hGLP - 1)基因 ,高效表达GST - 2 Gly -hGLP - 1融合蛋白。方法 :在获得重组hGLP - 1基因工程菌基础上 ,利用定点突变技术改造其第 2位丙氨酸为甘氨酸 ,经酶切克隆于pGEM - 7z(+)载体中 ,构建pGEM - 7z(+) / 2 Gly -hGLP - 1克隆载体 ,双酶切鉴定后把2 Gly-hGLP - 1基因定向插入pGEX - 4T - 3多克隆位点 ,构建pGEX- 4T - 3/ 2 Gly-hGLP - 1融合表达载体 ,转化大肠杆菌BL2 1(DE3)并进行诱导表达。结果 :经双酶切鉴定和测序分析 ,证明2 Gly-hGLP - 1基因已克隆到pGEX - 4T - 3载体中。SDS -PAGE和凝胶扫描分析 ,融合蛋白以可溶形式存在 ,其表达量占菌体总蛋白的 2 9.7%。表达产物经亲和层析纯化后纯度在 95 %以上 ,免疫印迹证实 ,该融合蛋白可被特异性hGLP - 1(7- 37)抗体所识别。结论 :为产业化规模制备hGLP - Objective:To clone the gene of hGLP-1 mutant and express the GST-2Gly-hGLP-1 fusion protein.Methods:Using recombinant hGLP-1expression system,the 2nd alanine was changed to be glycine by means of site-directed mutagenesis.The mutant gene was cloned to the plasmid vector pGEM-7z(+) after appropriate cleavage with restrictive endonuclease and then inserted into the MCS of the fusion expression vector pGEX-4T-3.The recombinant plasmid was transformed into E.coli.BL21(DE3) and induced by IPTG.Results:The recombinant plasmid DNA was digested with BamHⅠand XhoⅠand hGLP-1 gene mutation was testified by DNA sequencing.The results demonstrated that the mutated 2Gly-hGLP-1 was successfully inserted into the pGEX-4T-3 vector.SDS-PAGE and scan analysis showed the fusion protein GST-2Gly-hGLP-1 was expressed in a soluble form and amounted to 29.7% of the total bacterial protein.The purity of GST-2Gly-hGLP-1 was more than 95% through affinity chromatography.Western blot analysis of fusion protein confirmed that it could be specially recognized by the antibody of hGLP-1(7-37).Conclusion:This study established foundation for further obtaining a larger quantity of recombinant hGLP-1 mutant for experimental and clinic studies.
出处 《生物技术》 CAS CSCD 2004年第3期4-6,共3页 Biotechnology
基金 太原市科技局启明星计划资助项目 (2 0 0 2 )
关键词 人胰高血糖素样肽-1 突变体 基因克隆 诱导表达 融合蛋白 SDS-PAGE 纯化 human glucagon-like peptide-1 mutant gene cloning induction expression fusion protein SDS-PAGE purification
  • 相关文献

参考文献16

  • 1Pospisilik JA, Stafford SG, Demuth HU, et al. Long - term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia, and beta - cell glucose responsi - veness in V
  • 2Deacon C F, Knudsen L B, Madson K, et al. Dipeptidyl- peptidase Ⅳ resistant analogues of glucagon - like peptide - 1 which have extended metabolic stability and improved biological activity [ J ]. Diabetologia, 1998,41 ( 3 ): 1 - 271- 278.
  • 3Nauck M A, Niedereichholz U, Ettler R, et al. Glucagon - like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans[J]. Am J Physiol, 1997,273(5Pt1 ) :E981 - 988.
  • 4Mentlein R. Dipeptidyl- peptidase IV (CD26) - role in the inactivation of regulatory peptides[ J ]. Regul Pept, 1999,85: 9 - 24.
  • 5Conarello SL, Li Z, Ronan J, et al. Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance [ J ]. Proc Natl Acad Sci USA,2003,100( 11 ) :6825 - 6830.
  • 6Hinke S A, Kuhn - Wache K, Hoffmann T, et al. Metformin effects on dipeptidyl peptidase IV degradation of glucagon - like peptide- 1 [ J]. Biochem Biophys Res Commun, 2002,291 ( 5 ): 1302 - 1308.
  • 7Siegel E G, Gzllwitz B, Scharf G, et al. Biological activity of GLP - 1 - analogues with N - terminal modifications[J]. Regul Pept, 1999,79(2 - 3) :93 -102.
  • 8Holz GG, Chepurny OG. Glucagon- like peptide- 1 synthetic analogs: new therapeutic agents for use in the treatment of diabetes mellitus[J]. Curr Med Chem, 2003,10(22) :2471 - 2483.
  • 9Radosavljevic T, Todorovic V, Sikic B. Role of glucagon - like peptide 1(GLP - 1 ) in regulation of insulin secretion[J]. Srp Arh Celok Lek,2002,130(11 - 12) :416-419.
  • 10Holst J J. Glucagon - like peptide- 1, a gastrointesnal hormone with a pharmaceutical potential[ J]. Curr Medd Chem, 1999,6( 11 ): 1005 - 1017.

二级参考文献2

共引文献21

同被引文献72

  • 1张志珍,毛积芳,杨生生.重组人胰高血糖素样肽-1对实验性糖尿病大鼠血糖的影响[J].中国生化药物杂志,2004,25(5):287-290. 被引量:5
  • 2奥斯伯F 颜自颖等(译).精编分子生物学实验指南(第3版)[M].北京:科学出版社,1998.691-694.
  • 3高虹,宁光.胰高血糖素样肽1的胰腺外作用研究进展[J].国际内科学杂志,2007,34(7):408-411. 被引量:25
  • 4Hoist J J, Gromada J. Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans[J]. Am J Physiol Endocrinol Metab, 2004,287(2):E199-206.
  • 5Gutzwiller J P, Tschopp S, Bock A, et al. Glucagon-like peptide-1 induces natriuresis in healthy subjects and in insulin resistant obesemen [J]. J Clin Endocrinol Metab, 2004,89(6): 3055-3061.
  • 6Scrocchi L A, Brown T J, Maclusky N, et al. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide-I receptor gene[J]. Nat Med, 1996,2(11): 1254-1258.
  • 7During M J, Cao L, Zuzga D S, et al. Glucagon-like peptide -1 receptor is involved in learning and neuroprotection[J]. Nat Med, 2003,9(9):1173-1179.
  • 8Nystrom T, Gonon A T, Sjoholm A, et al. Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism[J]. Regul Pept, 2005,125(1-3):173-177.
  • 9Baggio L L, Drucker D J. Clincal endocrinology and metabolism. Glucagon-like peptide-1 and glucagons-like peptide-2[J]. Best Pract Res Clin Endocrinol Metab, 2004,18(4):531-554.
  • 10Eng J, Kleinman W A, Singh L, et al. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas [J]. J Biol Chem, 1992,267(11):7402-7405.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部